Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Innovent Releases the ORIENT-31 Phase 3 Study First Interim Analysis Results of Sintilimab …,

The study has shown the clinical value of adding sintilimab plus BYVASDA® … including more than 10 registrational or pivotal clinical trials., The study has shown the clinical value of adding sintilimab plus BYVASDA® … including more than 10 registrational or pivotal clinical trials., Read More

Scroll to Top